Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS

por Cremonini, F, Nicandro, J P, Atkinson, V, Shringarpure, R, Chuang, E, Lembo, A
Publicado 2012

Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity

por Pimentel, M., Cash, B. D., Lembo, A., Wolf, R. A., Israel, R. J., Schoenfeld, P.
Publicado 2017

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials...

por Schoenfeld, P., Pimentel, M., Chang, L., Lembo, A., Chey, W. D., Yu, J., Paterson, C., Bortey, E., Forbes, W. P.
Publicado 2014

Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-C

por Lacy, B E, Lembo, A J, MacDougall, J E, Shiff, S J, Kurtz, C B, Currie, M G, Johnston, J M
Publicado 2014

Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome

por Marquis, P, Lasch, K E, Delgado-Herrera, L, Kothari, S, Lembo, A, Lademacher, C, Spears, G, Nishida, A, Tesler, Waldman L, Piault, E, Rosa, K, Zeiher, B
Publicado 2014

The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised,...

por Chang, L, Lembo, A J, Lavins, B J, Shiff, S J, Hao, X, Chickering, J G, Jia, X D, Currie, M G, Kurtz, C B, Johnston, J M
Publicado 2014